Exhibit 12.1
SALIX PHARMACEUTICALS, LTD.
COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
(in thousands)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Quarter Ended March 31, | | | Year Ended December 31, | |
| | 2014 | | | 2013 | | | 2013 | | | 2012 | | | 2011 | | | 2010 | | | 2009 | |
EARNINGS (LOSS) | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net income (loss) before provision for income tax (1) | | $ | (80,240 | ) | | $ | 33,959 | | | $ | 212,065 | | | $ | 111,828 | | | $ | 86,101 | | | $ | (24,203 | ) | | $ | (45,631 | ) |
Fixed charges (1) | | | 43,078 | | | | 15,628 | | | | 62,891 | | | | 56,667 | | | | 32,879 | | | | 21,141 | | | | 7,275 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
Net Income (loss) before provision for income tax plus fixed charges | | $ | (37,162 | ) | | $ | 49,587 | | | $ | 274,956 | | | $ | 168,495 | | | $ | 118,980 | | | $ | (3,062 | ) | | $ | (38,356 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
FIXED CHARGES | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Interest expense (1) | | $ | 29,275 | | | $ | 5,131 | | | $ | 20,267 | | | $ | 19,766 | | | $ | 12,760 | | | $ | 8,857 | | | $ | 3,594 | |
Amortization of debt issuance costs and debt discount | | | 13,185 | | | | 10,198 | | | | 41,383 | | | | 35,752 | | | | 19,361 | | | | 11,795 | | | | 3,151 | |
Estimate of interest within rental expense | | | 618 | | | | 299 | | | | 1,241 | | | | 1,149 | | | | 758 | | | | 489 | | | | 530 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
Fixed Charges | | $ | 43,078 | | | $ | 15,628 | | | $ | 62,891 | | | $ | 56,667 | | | $ | 32,879 | | | $ | 21,141 | | | $ | 7,275 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
RATIO OF EARNINGS TO FIXED CHARGES | | | — | | | | 3.17 | | | | 4.37 | | | | 2.97 | | | | 3.62 | | | | — | | | | — | |
| | | | | | | |
COVERAGE DEFICIENCY (2) | | $ | (80,240 | ) | | $ | — | | | $ | — | | | $ | — | | | $ | — | | | $ | (24,203 | ) | | $ | (45,631 | ) |
(1) | For the quarter ended March 31, 2014, income before taxes and fixed charges include $ 0.5 million of interest expense related to uncertain tax positions. |
(2) | Earnings were inadequate to cover fixed charges for the years ended December 31, 2010 and 2009 and the quarter ended March 31, 2014. As a result, a coverage deficiency is provided for those periods presented in which earnings were inadequate to cover fixed charges. |